2024 EVENT GUIDE

Thank you to our speakers, sponsors, and delegates who joined us for the summit! If you are interested in the 2025 event, please get in touch at info@hansonwade.com

Get Your Copy of the 2024 Full Event Guide Now:

Download the comprehensive event guide to view the complete agenda, the speaker line-up, networking opportunities and much more!

What Did We Have?

  • 70+ Hippo pathway experts and drug developers
  • 20+ expert speakers
  • 5+ hours of built-in networking time
  • 4 interactive and deep-diving panels

*Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Catch the Latest Clinical Data from Leading Hippo Companies:

Journey of VT3989: Clinical Insights & Overcoming Challenges

Neelesh Sharma, Chief Medical Officer, Vivace Therapeutics

Neelesh Sharma, Hippo Pathway Targeted Drug Development Summit

Presenting a Novel Pan TEAD Inhibitor to Treat Hippo Pathway Dysregulated Tumors

Michelle Chen, Chief Business Officer, Insilico Medicine

Michelle Chen, Hippo Pathway Targeted Drug Development Summit

Discovery & Development of a Novel Covalent TEAD Inhibitor with Exceptional Anti-Cancer Activity & Druggability

Shirley Guo, Director of Biology, BridGene Biosciences

Shirley Guo, Hippo Pathway Targeted Drug Development Summit
REGISTER INTEREST FOR THE 2025 EVENT

Your next meeting in the series:

Covalent-Drug-Discovery-Summit-Strapline-1024x210

December 10-12, 2024 | Boston, MA

UPCOMING EVENTS IN THE SMALL MOLECULES SERIES